Correlation Between Zenas BioPharma, and Orgenesis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zenas BioPharma, and Orgenesis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zenas BioPharma, and Orgenesis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zenas BioPharma, Common and Orgenesis, you can compare the effects of market volatilities on Zenas BioPharma, and Orgenesis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zenas BioPharma, with a short position of Orgenesis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zenas BioPharma, and Orgenesis.

Diversification Opportunities for Zenas BioPharma, and Orgenesis

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Zenas and Orgenesis is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Zenas BioPharma, Common and Orgenesis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orgenesis and Zenas BioPharma, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zenas BioPharma, Common are associated (or correlated) with Orgenesis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orgenesis has no effect on the direction of Zenas BioPharma, i.e., Zenas BioPharma, and Orgenesis go up and down completely randomly.

Pair Corralation between Zenas BioPharma, and Orgenesis

If you would invest  122.00  in Orgenesis on September 23, 2024 and sell it today you would earn a total of  0.00  from holding Orgenesis or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy4.76%
ValuesDaily Returns

Zenas BioPharma, Common  vs.  Orgenesis

 Performance 
       Timeline  
Zenas BioPharma, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zenas BioPharma, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Etf's forward indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the ETF investors.
Orgenesis 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Orgenesis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Zenas BioPharma, and Orgenesis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zenas BioPharma, and Orgenesis

The main advantage of trading using opposite Zenas BioPharma, and Orgenesis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zenas BioPharma, position performs unexpectedly, Orgenesis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orgenesis will offset losses from the drop in Orgenesis' long position.
The idea behind Zenas BioPharma, Common and Orgenesis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules